Invention Grant
- Patent Title: Single agent anti-PD-L1 and PD-L2 dual binding antibodies and methods of use
-
Application No.: US15806003Application Date: 2017-11-07
-
Publication No.: US10934353B2Publication Date: 2021-03-02
- Inventor: Gordon J. Freeman , Arlene H. Sharpe
- Applicant: Dana-Farber Cancer Institute, Inc. , President and Fellows of Harvard College
- Applicant Address: US MA Boston; US MA Cambridge
- Assignee: Dana-Farber Cancer Institute, Inc.,President and Fellows of Harvard College
- Current Assignee: Dana-Farber Cancer Institute, Inc.,President and Fellows of Harvard College
- Current Assignee Address: US MA Boston; US MA Cambridge
- Agency: Foley Hoag LLP
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A01K67/027 ; G01N33/574 ; G01N33/68
Abstract:
The present invention is based, in part, on the identification of novel antibodies that have binding affinity for both PD-L1 and PD-L2 and methods of using same.
Public/Granted literature
- US20180201680A1 SINGLE AGENT ANTI-PD-L1 AND PD-L2 DUAL BINDING ANTIBODIES AND METHODS OF USE Public/Granted day:2018-07-19
Information query
